These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 17328144

  • 1. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
    Czarnecka-Operacz M, Silny W.
    Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
    Silny W, Czarnecka-Operacz M, Silny P.
    Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
    [Abstract] [Full Text] [Related]

  • 3. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W, Czarnecka-Operacz M.
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
    Silny W, Czarnecka-Operacz M, Silny P.
    Wiad Lek; 2005 Dec; 58(3-4):184-92. PubMed ID: 16119162
    [Abstract] [Full Text] [Related]

  • 5. [Results of skin prick tests and evaluation of serum antigen specific immunoglobulin E in patients with atopic dermatitis and airborne allergy with regards to the type of sensitising allergens and seasonal course of the disease].
    Silny P, Czarnecka-Operacz M, Silny W.
    Pol Merkur Lekarski; 2005 Apr; 18(106):393-9. PubMed ID: 16161918
    [Abstract] [Full Text] [Related]

  • 6. Immunological parameters in the sera of patients with atopic dermatitis and airborne allergy treated with allergy vaccines.
    Czarnecka-Operacz M, Silny W.
    Acta Dermatovenerol Croat; 2006 Apr; 14(1):8-20. PubMed ID: 16603096
    [Abstract] [Full Text] [Related]

  • 7. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M, Jenerowicz D, Silny W.
    Acta Dermatovenerol Croat; 2008 Apr; 16(1):19-24. PubMed ID: 18358104
    [Abstract] [Full Text] [Related]

  • 8. Atopy patch test reaction to airborne allergens in the diagnosis of atopic dermatitis.
    Czarnecka-Operacz M, Bator-Wegner M, Silny W.
    Acta Dermatovenerol Croat; 2005 Apr; 13(1):3-16. PubMed ID: 15788141
    [Abstract] [Full Text] [Related]

  • 9. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S.
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of skin prick tests and serum concentration of antigen-specific immunoglobulin E in patients with atopic dermatitis sensitive to airborne allergens in relation to the type of allergens and age of patients].
    Silny P, Czarnecka-Operacz M, Silny W.
    Pol Merkur Lekarski; 2005 May; 18(107):544-8. PubMed ID: 16161952
    [Abstract] [Full Text] [Related]

  • 11. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, Bieber T, Thomas WR, Valenta R, Zuberbier T, Sager A, Novak N.
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [Abstract] [Full Text] [Related]

  • 12. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?
    Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N.
    J Allergy Clin Immunol; 2006 Dec; 118(6):1292-8. PubMed ID: 17157659
    [Abstract] [Full Text] [Related]

  • 13. [Effectiveness of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part III. Serum concentrations of selected immunologic parameters].
    Silny W, Czarnecka-Operacz M, Silny P.
    Wiad Lek; 2005 Dec; 58(5-6):287-94. PubMed ID: 16238119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Non-allergic type of atopic dermatitis among patients of Allergic Diseases Diagnostic Center, University of Medical Sciences in Poznań].
    Czarnecka-Operacz M, Jenerowicz D, Silny W.
    Przegl Lek; 2005 Dec; 62(12):1332-6. PubMed ID: 16786742
    [Abstract] [Full Text] [Related]

  • 19. [Role of immediate hypersensitivity to airborne allergens in the pathogenesis of atopic dermatitis].
    Silny P, Czarnecka-Operacz M, Silny W.
    Pol Merkur Lekarski; 2004 Mar; 16(93):245-50. PubMed ID: 15190601
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis.
    Novak N, Thaci D, Hoffmann M, Fölster-Holst R, Biedermann T, Homey B, Schaekel K, Stefan JA, Werfel T, Bieber T, Sager A, Zuberbier T.
    Int Arch Allergy Immunol; 2011 Mar; 155(3):252-6. PubMed ID: 21293143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.